All News #Library
Biotech
Structure Climbs on ‘Competitive’ Profile for Weight Loss Pill
16 Mar 2026 //
BIOSPACE
Structure Therapeutics Initiates Phase 1 Study Of Oral ACCG-2671
17 Dec 2025 //
GLOBENEWSWIRE
Structure Announces Closing of Upsized $747.5 M Public Offering
11 Dec 2025 //
GLOBENEWSWIRE
Structure Therapeutics: Positive Aleniglipron Data
08 Dec 2025 //
GLOBENEWSWIRE
Wave, Structure stocks double on obesity data readouts
08 Dec 2025 //
FIERCE BIOTECH
Structure Therapeutic to Report Data from ACCESS Clinical Program
07 Dec 2025 //
GLOBENEWSWIRE
Structure Therapeutics Reports Q1 Financial Results and Highlight
08 May 2025 //
GLOBENEWSWIRE
Structure Therapeutics Selects ACCG-2671 for Obesity Treatment
17 Dec 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support